Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02391948 · ClinicalTrials.gov registry record
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 724
- Enrollment target
NCT02391948: Completed study, sponsored by University of Washington.
NCT02391948 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 724 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02391948 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 724 participants
- Enrollment target
Study Summary
The On Track Study is a large multi-site collaboration involving researchers, therapists, families, and children with cerebral palsy (CP) from across Canada and the United States. The researchers need to better understand how young children who have difficulties with movement activities progress and develop in their balance abilities, fitness, strength, health, range of motion, self-care, everyday play, and activity participation. This study will determine how young children with cerebral palsy or gross motor delays progress in many aspects of their physical development and participation in daily life. The information collected from this study will help therapists and parents monitor if a child is developing as expected in his or her physical development and participation. Then, the health care professionals working with children can use the results of this study, in combination with the previously completed Move \& PLAY study results, to provide the services that are most beneficial and meaningful for each child and their family members.
Primary Outcome
The ECAB addresses postural control and balance across the developmental sequence. Part I has 7 items (with numbers 1,4,5,6,7 scored bilaterally): 1) lateral head righting, 2) head righting in extension, 3) head righting in flexion, 4) rotation in the trunk, 5) equilibrium reactions in sitting, 6) protective extension to the side, and 7) protective extension backwards. The items are scored on a scale of 0 = no response to 3 = complete \& consistent response. Part II has 6 items: 1) sitting with
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 724 participants |
| Start Date | 2013-07-01 |
| Est. Completion | 2017-03-31 |
What the finished NCT02391948 record still lists
NCT02391948 is an observational study that tracks outcomes without assigning an intervention. The registered 724 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02391948 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02391948 about?
NCT02391948 is a clinical study titled "On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay". The On Track Study is a large multi-site collaboration involving researchers, therapists, families, and children with cerebral palsy (CP) from across Canada and the United States. The researchers need to better understand how young children who have difficulties with movement activities progress and...
What is the current status of trial NCT02391948?
This trial is currently completed. The enrollment target is 724 participants. The study started on 2013-07-01. Estimated completion is 2017-03-31.
Who is sponsoring clinical trial NCT02391948?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06664619 · 724 participants · Phase 3
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- NCT05634967 · 725 participants
Kesimpta (Ofatumumab) Pregnancy Registry
- NCT06641466 · 723 participants · Phase 3
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
- NCT07088068 · 723 participants · Phase 3
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI